Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 13, 2024, titled "CuraTeQ Biologics receives positive opinion for biosimilar Zefylti".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 13, 2024, titled "CuraTeQ Biologics receives positive opinion for biosimilar Zefylti".